注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Innate Pharma SA是一家主要开发用于治疗癌症和炎症性疾病的药物的法国生物制药公司。该公司确定候选药物并对其进行表征,选择适应症并管理产品的临床前和临床开发。该公司主要从事研发新的治疗解决方案和单克隆抗体,用于治疗癌症、传染病和慢性炎症性疾病。 该公司开发了两类免疫疗法:免疫调节剂和细胞毒性抗体。该公司与百时美施贵宝合作进行一期癌症抗体计划,并与诺和诺德合作进行两项炎症治疗抗体计划。该公司通过anti-NKG2A抗体,一种诺和诺德的肿瘤学二期免疫检查点抑制剂,来开展业务。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Mailys Ferrere | 59 | 2017 | Member of Supervisory Board |
Gilles Brisson | 72 | 2007 | Independent Member of Supervisory Board |
Irina Staatz-Granzer | 64 | 2009 | Independent Chairwoman of Supervisory Board |
Ruslan Medzhitov | - | 2018 | Strategic Advisory Board Member |
Tanguy Seiwert | - | 2018 | Strategic Advisory Board Member |
Mario Sznol | 66 | 2018 | Strategic Advisory Board Member |
Aurelien Marabelle | - | 2018 | Strategic Advisory Board Member |
Olivier Martinez | 54 | 2010 | Member of Supervisory Board |
Sebastian Amigorena | - | 2018 | Strategic Advisory Board Member |
Jean-Yves Blay | 62 | 2017 | Independent Member of Supervisory Board |
Veronique Chabernaud | 63 | 2015 | Independent Member of Supervisory Board |
Miriam Merad | - | 2018 | Chairman of Strategic Advisory Board |
Pascale Boissel | 58 | 2020 | Independent Vice Chairperson of the Supervisory Board |
Sally L. Bennett | 52 | 2022 | Independent Supervisory Board Member |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核